Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors
Position in AZN — Astrazeneca PLC
CIK 1748861
CONCORD, MA
Position in AZN
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$2,487,245
-$103,831 QoQ
Shares Held
13,117
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#487
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors holds $23,196,345 across 9 Drug Manufacturers - General names. AZN ranks #5 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,083 | $6,096,703 | |
| 2 | AMGN |
Amgen Inc
|
12,802 | $4,635,860 | |
| 3 | JNJ |
Johnson & Johnson
|
15,152 | $3,848,153 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,685 | $2,658,022 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
13,117 | $2,487,245 | |
| 6 | ABBV |
AbbVie Inc.
|
8,670 | $2,181,718 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,883 | $490,578 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
7,151 | $412,040 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,487,245 | 13,117 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $2,591,076 | 13,138 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||